Trump to Announce Nationwide Medicaid Drug Pricing Plan

President Donald Trump is slated to address the nation on Friday with a new initiative aimed at reducing prescription‑drug costs. In the remarks, the president will announce that Medicaid programs in all 50 states will be granted “most‑favored‑nation” pricing for a selected group of medications, a policy designed to align state drug purchases with the lowest prices available internationally. The announcement will be made in the Oval Office, where several governors are expected to join the president to underscore the bipartisan support for the measure.

The proposed pricing framework seeks to leverage the purchasing power of Medicaid to secure lower rates from pharmaceutical manufacturers, potentially saving billions of dollars for state budgets and beneficiaries. Officials indicated that the policy will apply to high‑cost, brand‑name drugs that currently lack competitive pricing, and that the administration will work with Congress and the Department of Health and Human Services to implement the changes. If enacted, the move would mark a significant expansion of the federal government’s efforts to curb drug expenses for low‑income patients across the country.